
FDA aligns with Cognition on a phase 3 zervimesine trial for Lewy body dementia, testing 100 mg daily for 9 months to target hallucinations.
How do social stressors contribute to patient symptoms?
John J. Miller, MD, briefly discusses how disruptions in social life can cause change in primary symptoms. Psychosocial stressors have been key talking point at the 2022 APA Annual Meeting in New Orleans.
For more from the conference, check out the
Dr Miller is medical director, Brain Health, Exeter, New Hampshire; Editor in Chief, Psychiatric TimesTM; staff psychiatrist, Seacoast Mental Health Center, Exeter; Consulting Psychiatrist, Exeter Hospital, Exeter; consulting psychiatrist, Insight Meditation Society, Barre, Massachusetts.






